129 related articles for article (PubMed ID: 26967258)
1. Incidence and Management of Glaucoma in Vogt Koyanagi Harada Disease.
Pandey A; Balekudaru S; Venkatramani DV; George AE; Lingam V; Biswas J
J Glaucoma; 2016 Aug; 25(8):674-80. PubMed ID: 26967258
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, risk factors and management of ocular hypertension or glaucoma in patients with Vogt-Koyanagi-Harada disease.
Yang P; Wang C; Su G; Pan S; Qin Y; Zhang J; Cao Q; Zhong Z; Zhou C; Wang Y; Kijlstra A
Br J Ophthalmol; 2021 Dec; 105(12):1678-1682. PubMed ID: 33011689
[TBL] [Abstract][Full Text] [Related]
3. The Relationship of Vogt-Koyanagi-Harada Syndrome to Ocular Hypertension and Glaucoma.
Veerappan M; Fleischman D; Ulrich JN; Stinnett SS; Jaffe GJ; Allingham RR
Ocul Immunol Inflamm; 2017 Dec; 25(6):748-752. PubMed ID: 27438521
[TBL] [Abstract][Full Text] [Related]
4. Incidence and management of glaucoma in Vogt-Koyanagi-Harada syndrome.
Forster DJ; Rao NA; Hill RA; Nguyen QH; Baerveldt G
Ophthalmology; 1993 May; 100(5):613-8. PubMed ID: 8098519
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of angle-closure glaucoma in Vogt-Koyanagi-Harada disease.
Alvarez-Guzman C; Valdez-Garcia JE; Ruiz-Lozano RE; Rodriguez-Garcia A; Navas-Villar CF; Hartleben-Matkin C; Pedroza-Seres M
Int Ophthalmol; 2022 Dec; 42(12):3913-3921. PubMed ID: 35789316
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Trabeculectomy With Mitomycin-C in Uveitis Associated With Vogt-Koyanagi-Harada Disease.
Almobarak FA; Alharbi AH; Morales J; Aljadaan I
J Glaucoma; 2016 Jun; 25(6):528-32. PubMed ID: 26900830
[TBL] [Abstract][Full Text] [Related]
7. Phacoemulsification after trabeculectomy in uveitis associated with Vogt-Koyanagi-Harada disease: intermediate-term visual outcome, IOP control and trabeculectomy survival.
Almobarak FA; Alharbi AH; Aljadaan I; Aldhibi H
BMC Ophthalmol; 2022 May; 22(1):210. PubMed ID: 35534801
[TBL] [Abstract][Full Text] [Related]
8. Incidence and pre/post-treatment risk factors of glaucoma in Vogt-Koyanagi-Harada disease.
Yoshitomi S; Harada Y; Hiyama T; Yuasa Y; Hirooka K; Kiuchi Y
Int Ophthalmol; 2023 Aug; 43(8):2857-2866. PubMed ID: 36929369
[TBL] [Abstract][Full Text] [Related]
9. Band-shaped keratopathy in Chinese patients with Vogt-Koyanagi-Harada syndrome.
Yang P; Sun M
Cornea; 2011 Dec; 30(12):1336-40. PubMed ID: 21934492
[TBL] [Abstract][Full Text] [Related]
10. Vogt-Koyanagi-Harada disease presenting as acute angle closure glaucoma at onset.
Yang P; Liu X; Zhou H; Guo W; Zhou C; Kijlstra A
Clin Exp Ophthalmol; 2011; 39(7):639-47. PubMed ID: 22452682
[TBL] [Abstract][Full Text] [Related]
11. Vogt-Koyanagi-Harada disease in Thailand.
Yodmuang T; Rothova A; Kunavisarut P; Pathanapitoon K
Ocul Immunol Inflamm; 2012 Dec; 20(6):419-22. PubMed ID: 23163754
[TBL] [Abstract][Full Text] [Related]
12. Complications and prognostic factors in Vogt-Koyanagi-Harada disease.
Read RW; Rechodouni A; Butani N; Johnston R; LaBree LD; Smith RE; Rao NA
Am J Ophthalmol; 2001 May; 131(5):599-606. PubMed ID: 11336934
[TBL] [Abstract][Full Text] [Related]
13. Incidence, Risk Factors and Surgical Outcomes of Cataract among Patients with Vogt-Koyanagi-Harada Disease.
AlBloushi AF; Alfawaz AM; AlZaid A; Alsalamah AK; Gikandi PW; Abu El-Asrar AM
Ocul Immunol Inflamm; 2021 Jan; 29(1):128-136. PubMed ID: 31638886
[No Abstract] [Full Text] [Related]
14. Bilateral acute angle closure glaucoma as a presentation of vogt-koyanagi-harada syndrome in four chinese patients: a small case series.
Yao J; Chen Y; Shao T; Ling Z; Wang W; Qian S
Ocul Immunol Inflamm; 2013 Aug; 21(4):286-91. PubMed ID: 23718571
[TBL] [Abstract][Full Text] [Related]
15. Bilateral acute angle closure glaucoma as an initial presentation of Vogt-Koyanagi-Harada syndrome: A clinical case report.
Yuan F; Zhang Y; Yan X
Eur J Ophthalmol; 2022 Jan; 32(1):NP230-NP234. PubMed ID: 32811185
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for Vogt-Koyanagi-Harada disease.
Sheu SJ; Kou HK; Chen JF
J Chin Med Assoc; 2003 Mar; 66(3):148-54. PubMed ID: 12779034
[TBL] [Abstract][Full Text] [Related]
17. Vogt-Koyanagi-Harada disease in children.
Abu El-Asrar AM; Al-Kharashi AS; Aldibhi H; Al-Fraykh H; Kangave D
Eye (Lond); 2008 Sep; 22(9):1124-31. PubMed ID: 17479116
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
[TBL] [Abstract][Full Text] [Related]
19. Analysis of 87 cases with Vogt-Koyanagi-Harada disease.
Mondkar SV; Biswas J; Ganesh SK
Jpn J Ophthalmol; 2000; 44(3):296-301. PubMed ID: 10913650
[TBL] [Abstract][Full Text] [Related]
20. A clinical evaluation of uveitis-associated secondary glaucoma.
Takahashi T; Ohtani S; Miyata K; Miyata N; Shirato S; Mochizuki M
Jpn J Ophthalmol; 2002; 46(5):556-62. PubMed ID: 12457916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
